TECZEM
LOE Approachingdiltiazem malate; enalapril maleate
NDAORALTABLET, EXTENDED RELEASE
Approved
Oct 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 13h ago · AI intelligence enriched 2mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TECZEM is a fixed-dose combination oral tablet combining diltiazem (a calcium channel blocker) and enalapril (an ACE inhibitor) in extended-release formulation. It is indicated for hypertension management in patients who require dual antihypertensive therapy. This combination addresses both vascular and neurohormonal pathways to reduce blood pressure.
LOE Approaching
As an aging combination product approaching loss of exclusivity with moderate competitive pressure (30%), this brand is in transition and likely operating with minimal team expansion or stable headcount focused on managed care and legacy patient retention.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on TECZEM offers limited growth trajectory and is best suited for professionals managing declining or niche brands, supporting legacy patient populations, or transitioning to newer products. This role emphasizes operational efficiency, managed care navigation, and defensive commercial strategy rather than innovative launch or expansion activities.
Brand Manager
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.